1. Roles of Toll-Like Receptor 3 in Human Tumors
   Xin Zheng et al, 2021, Frontiers in Immunology CrossRef
2. Toll-like receptors in pathophysiology of liver diseases
   Safak Kiziltas, 2016, World Journal of Hepatology CrossRef
3. Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
   D. M. Abarca-Merlin et al, 2019, BioMed Research International CrossRef
4. Liposomes-Encapsulating Double-Stranded Nucleic Acid (Poly I:C) for Head and Neck Cancer Treatment
   Vidit Singh et al, 2024, ACS Pharmacology & Translational Science CrossRef
5. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
   Yang Yang et al, 2022, Frontiers in Immunology CrossRef
6. Cell Surface Expression of Endosomal Toll-Like Receptors—A Necessity or a Superfluous Duplication?
   Matylda Barbara Mielcarska et al, 2021, Frontiers in Immunology CrossRef
7. TLR3 Plays Significant Roles against HBV-Associated HCC
   Xiao-lan Chen et al, 2015, Gastroenterology Research and Practice CrossRef
8. Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?
   Jorge André Gomes Lopes, 2016, World Journal of Hepatology CrossRef
9. Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant
   Bo Jin et al, 2010, Journal of Biomedicine and Biotechnology CrossRef
10. Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation
    Apriliana E. R. Kartikasari et al, 2019, Frontiers in Immunology CrossRef
11. Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
    Kai Naumann et al, 2013, Clinical and Developmental Immunology CrossRef
12. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
    Stefania Cuzzubbo et al, 2021, Frontiers in Immunology CrossRef
13. Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy
    Yinglu Feng et al, 2018, OncoImmunology CrossRef